Escalon Medical Corp.
Financial ratios & Valuation

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-19.71-5.10-2.13.48-3.60-0.67-20.3851.904.05-8.43-0.85-3.60
Price/Sales ratio
0.810.500.130.170.090.100.140.080.150.080.040.10
Price/Book Value ratio
3.563.071.280.840.410.631.060.630.950.580.420.41
Price/Cash Flow ratio
-23.37-4.91-3.0119.04-1.88-5.721.85-0.895.70-1.75-0.46-1.88
Price/Free Cash Flow ratio
-21.65-4.69-2.9631.32-1.79-4.221.87-0.895.95-1.64-0.46-1.79
Price/Earnings Growth ratio
-0.46-0.040.06-0.020.02-0.000.21-0.420.000.06-0.00-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
46.66%46.46%45.88%44.75%48.08%44.70%42.27%43.04%45.00%42.95%43.37%44.70%
Operating Profit Margin
-8.00%-9.85%-5.57%1.79%-2.62%-0.33%-0.28%0.34%3.92%-0.87%-5.05%-0.33%
Pretax Profit Margin
-8.00%-9.94%-6.47%5.11%-2.59%-6.91%-0.49%0.16%3.75%-1.04%-5.23%-6.91%
Net Profit Margin
-4.12%-9.94%-6.47%5.11%-2.56%-15.14%-0.72%0.16%3.75%-1.04%-5.23%-15.14%
Effective Tax Rate
48.54%-0.01%-13.80%86.45%1.17%-118.86%-46.84%101.79%-4749.10%N/AN/A-118.86%
Return on Assets
-8.26%-20.82%-14.58%10.75%-4.81%-24.87%-1.34%0.34%8.60%-2.63%-12.33%-24.87%
Return On Equity
-18.10%-60.27%-61.41%24.19%-11.42%-94.13%-5.23%1.22%23.61%-6.92%-43.93%-94.13%
Return on Capital Employed
-27.78%-41.52%-31.61%6.43%-8.82%-1.10%-1.32%1.68%19.49%-5.00%-32.88%-1.10%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A1.28N/A
Quick Ratio
1.280.870.741.221.070.880.930.861.061.040.500.88
Cash ratio
0.540.190.180.380.180.280.480.190.310.070.100.28
Days of Sales Outstanding
49.6250.9048.2044.4056.7250.9837.7052.5749.5564.7039.6550.98
Days of Inventory outstanding
115.62134.46115.13105.64137.22125.3485.5596.0386.5286.13111.00125.34
Operating Cycle
165.24185.36163.34150.05193.95176.32123.25148.61136.08150.84120.78176.32
Days of Payables Outstanding
54.3964.3062.8830.6448.6753.4166.5560.6165.6872.4777.8948.67
Cash Conversion Cycle
110.85121.06100.46119.40145.27122.9156.7087.9970.3978.37-10.86122.91
Debt Ratios
Debt Ratio
N/A0.040.150.030.040.150.150.060.060.060.750.04
Debt Equity Ratio
N/A0.140.670.070.100.570.590.240.170.173.030.10
Long-term Debt to Capitalization
N/AN/AN/A0.000.000.220.090.090.130.130.240.00
Total Debt to Capitalization
N/A0.120.400.070.090.360.370.190.150.140.430.09
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-27.08N/A
Cash Flow to Debt Ratio
N/A-4.35-0.630.57-2.14-0.190.97-2.900.93-1.95-1.17-2.14
Company Equity Multiplier
2.192.894.212.242.373.783.893.492.742.624.032.37
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.03-0.10-0.040.00-0.04-0.010.08-0.090.02-0.05-0.09-0.01
Free Cash Flow / Operating Cash Flow Ratio
1.071.041.010.601.041.350.9810.951.061.001.35
Cash Flow Coverage Ratio
N/A-4.35-0.630.57-2.14-0.190.97-2.900.93-1.95-1.17-2.14
Short Term Coverage Ratio
N/A-4.35-0.630.63-2.30-0.391.18-5.048.08-16.13-2.02-2.30
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A